PAREXEL introduces next generation Perceptive MyTrials Analytics solution

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched the next generation of its Perceptive MyTrials® platform with advanced analytics capabilities. With the Perceptive MyTrials Analytics solution, clinical trial sponsors can now use a mobile-enabled, single entry-point to access predictive data analytics for multiple studies simultaneously. The solution offers real-time and aggregated analytics allowing sponsors and PAREXEL® clinical research professionals to detect key signals and trends. The Perceptive MyTrials Analytics solution also offers cross-sponsor viewing options for clients who need to evaluate data from multiple sponsors.

"As clinical studies become more complex, there is a growing need for real-time and standardized data and analytics from multiple studies," said Xavier Flinois, President, PAREXEL Informatics. "Using the enhanced tools available with the Perceptive MyTrials Analytics solution, our clients can visualize trends across studies, garner reliable intelligence, and confidently make data-driven business decisions. This information will ultimately help reduce risk, increase clinical trial efficiency, and speed time to market for our clients and for patients."

Developed by PAREXEL Informatics, the Perceptive MyTrials® platform provides an integrated suite of applications for managing clinical trials. Perceptive MyTrials Analytics offers enhanced analytics capabilities and cross-study business intelligence from within the Perceptive MyTrials platform.

Flinois added, "At PAREXEL, our mission is to bring science to the real world by simplifying a client's journey at every step. Perceptive MyTrials Analytics is another example of the integrated solutions we are developing that incorporate optimized study management processes that leverage mobile and analytics as part of our broader 'SMAC' [social media, mobile, analytics, and cloud] technology approach."

Perceptive MyTrials® Analytics is available directly as part of PAREXEL clinical research services or via the Perceptive® Partner Program.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Parexel. (2019, June 17). PAREXEL introduces next generation Perceptive MyTrials Analytics solution. News-Medical. Retrieved on July 15, 2024 from

  • MLA

    Parexel. "PAREXEL introduces next generation Perceptive MyTrials Analytics solution". News-Medical. 15 July 2024. <>.

  • Chicago

    Parexel. "PAREXEL introduces next generation Perceptive MyTrials Analytics solution". News-Medical. (accessed July 15, 2024).

  • Harvard

    Parexel. 2019. PAREXEL introduces next generation Perceptive MyTrials Analytics solution. News-Medical, viewed 15 July 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
PAREXEL expands Perceptive MyTrials Data-Driven Monitoring solution